Figure-01 (Figure 01)
Atorvastatin Calcium
Product Images NDC 50090-4913
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 50090-4913). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure-02 (Figure 02)
This is a chart that shows the cumulative hazard percentage for Atorvastatin. The hazard ratio for Atorvastatin is 0.53 (95% CI 0.45-0.83) and it is maintained up to 4 years of follow-up.*
Figure-03 (Figure 03)
The text describes a graph or chart showing the percentage of subjects who experienced "E vert" (it is not clear what this refers to) in relation to two different medications: Horvastatin 10 mg and Sorvastatin 80 mg. The graph shows that Horvastatin had a lower percentage of subjects experiencing E vert, with a hazard ratio of 0.78 and a p-value of 0.0002. The rest of the text appears to be labels for the graph, indicating that it shows the time to the first major cardiovascular endpoint in years (labeled 1-4).*
Chemical-structure (Chemical Structure)
Label Image (Lbl500904913)
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
